Please go ahead. Faheem Hasnain Good morning, thank you for joining us for the Receptos second quarter 2014 earnings call. With me today are Graham Cooper, our Chief Financial Officer; and Sheila ...

SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver ...

SAN DIEGO, CA - September 20, 2010 - Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company, today announced the appointment of Faheem Hasnain as an independent director of ...

Ladies and gentlemen, thank you for standing by, and welcome to the Gossamer Bio Q4 Earnings Call. At this time all participants are in a listen-only mode. After the speakers presentation there will ...

Vertex Ventures HC has named George Golumbeski and Faheem Hasnain as executive advisers. The appointments position the VC fund to benefit from the input of industry veterans who, respectively, turned ...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease ...

Mr. Hasnain brings more than 20 years of experience in the pharmaceutical and biotechnology industries, with executive leadership roles at leading public companies, including Facet Biotech Corporation ...

Industry veteran will strengthen Receptos's clinical and commercial expertise in multiple sclerosis and expand activities including the potential to acquire additional focused therapeutic assets SAN ...

Good day, ladies and gentlemen. And welcome to the Receptos Third Quarter 2014 Earnings Conference Call. At this time all participants are in a listen-only mode. Later, we will conduct a ...

Welcome to the Receptos First Quarter 2015 Earnings Conference Call. [Operator Instructions]. I would now like to introduce your host for today's conference call, Chief Executive Officer Faheem ...

Good day, ladies and gentlemen, and welcome to the Receptos First Quarter 2014 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer ...